Evidence map›Paper›PMID 38592450›Full record

ArticleCancer research communications2024

Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment.

Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice U Osmanbeyoglu, Andres J Klein-Szanto, Kathy Cai, Joseph R Testa

Open access · goldAbstract read
In one paragraph

Article in Cancer research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. An overview of BAP1 biological functions and current therapeutics.Biochimica et biophysica acta. Reviews on cancer · 2025
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuwaraj KadariyaCancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.ORCID 0009-0006-9418-9642
Eleonora SementinoCancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.ORCID 0009-0002-6771-4115
Maggie RuanCancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.ORCID 0009-0003-2608-4556
Mitchell CheungCancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.ORCID 0009-0005-3140-6032
Parham HadikhaniDepartment of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-4832-4368
Hatice U OsmanbeyogluDepartment of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-3175-1777
Andres J Klein-SzantoHistopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania.ORCID 0000-0002-5533-9402
Kathy CaiHistopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania.ORCID 0000-0002-6034-3377
Joseph R TestaCancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.ORCID 0000-0003-1301-5175
Fox Chase Cancer Center · USUniversity of Pittsburgh · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXLR01CA175691 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI RAUSCHER III, FRANK JOSEPH, TESTA, JOSEPH R. · 2014 to 2018
$2.7M
Algorithms to link signaling pathways with transcriptional programs for precision medicineR00CA207871 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OSMANBEYOGLU, HATICE ULKU · 2019 to 2022
$738k
NCI NIH HHS P30 CA006927NCI NIH HHS R00 CA207871NCI NIH HHS R01 CA175691
6 · The paper itself

Abstract

Asbestos and BAP1 germline mutations are risk factors for malignant mesothelioma (MM). While it is well accepted that amphibole asbestos is carcinogenic, the role of serpentine (chrysotile) asbestos in MM has been debated. To address this controversy, we assessed whether minimal exposure to chrysotile could significantly increase the incidence and rate of MM onset in germline Bap1-mutant mice. With either crocidolite or chrysotile, and at each dose tested, MMs occurred at a significantly higher rate and earlier onset time in Bap1-mutant mice than in wild-type littermates. To explore the role of gene-environment interactions in MMs from Bap1-mutant mice, we investigated proinflammatory and protumorigenic factors and the tumor immune microenvironment (TIME). IHC and immunofluorescence staining showed an increased number of macrophages in granulomatous lesions and MMs. The relative number of CD163-positive (CD163+) M2 macrophages in chrysotile-induced MMs was consistently greater than in crocidolite-induced MMs, suggesting that chrysotile induces a more profound immunosuppressive response that creates favorable conditions for evading immune surveillance. MMs from Bap1-mutant mice showed upregulation of CD39/CD73-adenosine and C-C motif chemokine ligand 2 (Ccl2)/C-C motif chemokine receptor 2 (Ccr2) pathways, which together with upregulation of IL6 and IL10, promoted an immunosuppressive TIME, partly by attracting M2 macrophages. Interrogation of published human MM RNA sequencing (RNA-seq) data implicated these same immunosuppressive pathways and connections with CD163+ M2 macrophages. These findings indicate that increased M2 macrophages, along with upregulated CD39/CD73-adenosine and Ccl2/Ccr2 pathways, contribute to an immunosuppressive TIME in chrysotile-induced MMs of Bap1-mutant mice, suggesting that immunotherapeutic strategies targeting protumorigenic immune pathways could be beneficial in human BAP1 mutation carriers who develop MM. SIGNIFICANCE: We show that germline Bap1-mutant mice have enhanced susceptibility to MM upon minimal exposure to chrysotile asbestos, not only amphibole fibers. Chrysotile induced a more profound immune tumor response than crocidolite in Bap1-mutant mice by upregulating CD39/CD73-adenosine and Ccl2/Ccr2 pathways and recruiting more M2 macrophages, which together contributed to an immunosuppressive tumor microenvironment. Interrogation of human MM RNA-seq data revealed interconnected immunosuppressive pathways consistent with our mouse findings.

Indexed as

MesotheliomaMesothelioma, MalignantNeoplasms, MesothelialAdenosineAnimalsAsbestos, AmphiboleAsbestos, CrocidoliteAsbestos, SerpentineGerm CellsHumansImmunosuppressive AgentsMiceTumor MicroenvironmentAdenosineAsbestos, AmphiboleAsbestos, CrocidoliteAsbestos, SerpentineImmunosuppressive Agents

Identifiers

PMID38592450
PMCPMC11000687
OpenAlexW4394579508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.